HI-RES Trademark

Trademark Overview

On Thursday, April 18, 2019, a trademark application was filed for HI-RES with the United States Patent and Trademark Office. The USPTO has given the HI-RES trademark a serial number of 88391889. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 26, 2022. This trademark is owned by ResMed Pty Ltd. The HI-RES trademark is filed in the Medical Instrument Products category with the following description:

Medical device for treatment of circulatory disorders, namely, lymphatic obstruction, chronic venous insufficiency, and lymphedema
hi-res

General Information

Serial Number88391889
Word MarkHI-RES
Filing DateThursday, April 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements

Goods and ServicesMedical device for treatment of circulatory disorders, namely, lymphatic obstruction, chronic venous insufficiency, and lymphedema

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, May 5, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameResMed Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBella Vista, NSW 2153
AU
Party NameResMed Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBella Vista, NSW 2153
AU

Trademark Events

Event DateEvent Description
Tuesday, December 27, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 17, 2022SOU EXTENSION 5 GRANTED
Wednesday, May 11, 2022SOU EXTENSION 5 FILED
Tuesday, May 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 11, 2022TEAS EXTENSION RECEIVED
Saturday, October 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 21, 2021SOU EXTENSION 4 GRANTED
Thursday, October 21, 2021SOU EXTENSION 4 FILED
Thursday, October 21, 2021TEAS EXTENSION RECEIVED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021SOU EXTENSION 3 GRANTED
Thursday, May 13, 2021SOU EXTENSION 3 FILED
Thursday, May 13, 2021TEAS EXTENSION RECEIVED
Thursday, November 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 17, 2020SOU EXTENSION 2 GRANTED
Tuesday, November 17, 2020SOU EXTENSION 2 FILED
Tuesday, November 17, 2020TEAS EXTENSION RECEIVED
Wednesday, April 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 27, 2020SOU EXTENSION 1 GRANTED
Monday, April 27, 2020SOU EXTENSION 1 FILED
Monday, April 27, 2020TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 16, 2019ASSIGNED TO LIE
Thursday, August 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2019NON-FINAL ACTION E-MAILED
Monday, July 1, 2019NON-FINAL ACTION WRITTEN
Thursday, June 27, 2019ASSIGNED TO EXAMINER
Sunday, May 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 22, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

chronic obstruction venous insufficiency lymphedema lymphatic namely device treatment circulatory